After a heart attack, women shown to have worse prognosis when treated with beta-blockers | AI News Digest
A new analysis from the REBOOT clinical trial reveals significant sex-specific differences in the effects of beta-blockers after heart attacks. While men showed no benefit or risk from beta-blocker treatment, women experienced a 2.7% higher absolute risk of mortality and other adverse outcomes. The study highlights that women generally have a worse cardiovascular profile and prognosis compared to men. It suggests that a one-size-fits-all approach to prescribing beta-blockers may not be appropriate, emphasizing the need for personalized treatment strategies. These findings could reshape guidelines for post-heart attack therapies, particularly for women.
